lumretuzumab

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2016-2018
0120162018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Purpose To investigate the safety and clinical activity of comprehensive human epidermal growth factor receptor (HER) family… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2017
2017
Purpose: We evaluated biodistribution and tumor targeting of 89Zr-lumretuzumab before and during treatment with lumretuzumab, a… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2017
2017
Bidirectional cross talk between members of the human epidermal growth factor family of receptors (HER) and the estrogen receptor… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2017
2017
This study aimed at evaluating if pharmacokinetic and pharmacodynamic data from the first few patients treated with an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2017
2017
Purpose: This study investigated the safety, clinical activity, and target-associated biomarkers of lumretuzumab, a humanized… (More)
Is this relevant?
2016
2016
PURPOSE A first-in-human phase I study was conducted to characterize safety, efficacy, and pharmacokinetic (PK) and… (More)
Is this relevant?